Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 205

The DOI matches its Crossref record.

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial

Frech, Sarah A, DuPont, Herbert L, Bourgeois, A Louis, McKenzie, Robin, Belkind-Gerson, Jaime, Figueroa, Jose F, Okhuysen, Pablo C, Guerrero, Norma H, Martinez-Sandoval, Francisco G, Meléndez-Romero, Juan HM, Jiang, Zhi-Dong, Asturias, Edwin J, Halpern, Jane, Torres, Olga R, Hoffman, Ana S, Villar, Christina P, Kassem, Raniya N, Flyer, David C, Andersen, Bo H, Kazempour, Kazem, Breisch, Sally A, Glenn, Gregory M · 2008 · The Lancet

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(08)60839-9

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 27

  1. Black, 1990, Epidemiology of travelers' diarrhea and relative importance of various pathogens, Rev Infect Dis, 12, S73, 10.1093/clinids/12.Supplement_1.S73 · DOI · Paper page
  2. 1999, New frontiers in the development of vaccines against enterotoxigenic (ETEC) and enterohaemmorrhagic (EHEC) E coli infections, Wkly Epidemiol Rec, 74, 98
  3. Bouckenooghe, 2002, Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico, J Travel Med, 9, 137, 10.2310/7060.2002.23206 · doi:10.2310/7060.2002.23206
  4. Glenn, 2007, Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch, Expert Rev Vaccines, 6, 809, 10.1586/14760584.6.5.809 · DOI
  5. Glenn, 2007, Safety and immunogenicity of an ETEC vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum, Infect Immun, 75, 2163, 10.1128/IAI.01740-06 · DOI
  6. McKenzie, 2007, Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): Protective efficacy in a double-blind, placebo-controlled challenge study, Vaccine, 25, 3684, 10.1016/j.vaccine.2007.01.043 · DOI
  7. Freytag, 1999, Bacterial toxins as mucosal adjuvants, Curr Top Microbiol Immunol, 236, 215
  8. Steffen, 2005, Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea, J Travel Med, 12, 102, 10.2310/7060.2005.12207 · doi:10.2310/7060.2005.12207
  9. Qadri, 2005, Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6–17 months of age: Dosing studies in different age groups, Vaccine, 24, 1726, 10.1016/j.vaccine.2005.08.110 · doi:10.1016/j.vaccine.2005.08.110
  10. Sack, 2007, Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E coli diarrhoea of travellers to Guatemala and Mexico, Vaccine, 25, 4392, 10.1016/j.vaccine.2007.03.034 · doi:10.1016/j.vaccine.2007.03.034
  11. Steinsland, 2003, Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study, Lancet, 362, 286, 10.1016/S0140-6736(03)13971-2 · DOI
  12. Dupont, 1977, Diarrhea of travelers to Mexico. Relative susceptibility of United States and Latin American students attending a Mexican University, Am J Epidemiol, 105, 37, 10.1093/oxfordjournals.aje.a112353 · DOI
  13. Black, 1981, Enterotoxigenic Escherichia coli diarrhoea: acquired immunity and transmission in an endemic area, Bull World Health Organ, 59, 263
  14. Clemens, 1988, Cross-protection by B subunit-whole cell cholera vaccine against diarrhoea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial, J Infect Dis, 158, 372, 10.1093/infdis/158.2.372 · DOI
  15. Peltola, 1991, Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine, Lancet, 338, 1285, 10.1016/0140-6736(91)92590-X · DOI · Paper page
  16. Scerpella, 1995, Safety, immunogenicity, and protective efficacy of the whole-cell/recombinant B subunit (WC/rBS) oral cholera vaccine against travelers' diarrhea, J Travel Med, 2, 22, 10.1111/j.1708-8305.1995.tb00615.x · doi:10.1111/j.1708-8305.1995.tb00615.x
  17. Wiedermann, 2000, Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report), J Travel Med, 7, 27, 10.2310/7060.2000.00007 · doi:10.2310/7060.2000.00007
  18. Look, 2007, The adjuvant patch: a universal dose sparing approach for pandemic and conventional vaccines, BioPharm International: guide to vaccine development and manufacture, 20, 34
  19. Jiang, 2002, Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay), J Infect Dis, 185, 497, 10.1086/338834 · DOI · Paper page
  20. Adachi, 2001, Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world, Clin Infect Dis, 32, 1706, 10.1086/320756 · DOI · Paper page
  21. Jiang, 2000, Characterization of enterotoxigenic Escherichia coli strains in patients with travelers' diarrhea acquired in Guadalajara, Mexico, 1992–1997, J Infect Dis, 181, 779, 10.1086/315272 · DOI
  22. Taylor, 2006, A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea, Am J Trop Med Hyg, 74, 1060, 10.4269/ajtmh.2006.74.1060 · DOI
  23. Bourgeois AL, Halpertn J, Grahek S, et al Vaccination of travelers to Guatemala (GU) and Mexico (MX) with an oral killed vaccine (OKV) for enterotoxigenic E coli (ETEC): Impact of vaccine “take” on risk of ETEC disease and infection with enteric pathogens. 4th International Conference on Vaccines for Enteric Diseases (VED 2007). Lisbon, Portugal. April 25–27, 2007.
  24. Allen, 2006, Importance of heat-labile enterotoxin in colonization of the adult mouse small intestine by human enterotoxigenic Escherichia coli strains, Infect Immun, 74, 869, 10.1128/IAI.74.2.869-875.2006 · DOI
  25. Berberov, 2004, Relative importance of heat-labile enterotoxin in the causation of severe diarrheal disease in the gnotobiotic piglet model by a strain of enterotoxigenic Escherichia coli that produces multiple enterotoxins, Infect Immun, 72, 3914, 10.1128/IAI.72.7.3914-3924.2004 · doi:10.1128/iai.72.7.3914-3924.2004
  26. Zhang, 2006, Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunity, Infect Immun, 74, 3607, 10.1128/IAI.01836-05 · DOI
  27. Crane, 2006, Mutual enhancement of virulence by enterotoxigenic and enteropathogenic Escherichia coli, Infect Immun, 74, 1505, 10.1128/IAI.74.3.1505-1515.2006 · DOI

Cited by

See all 205

Metadata

Authors
Frech, S. A., DuPont, H. L., Bourgeois, A. L., McKenzie, R., Belkind-Gerson, J., Figueroa, J. F., Okhuysen, P. C., Guerrero, N. H., Martinez-Sandoval, F. G., Meléndez-Romero, J. H., Jiang, Z.-D., Asturias, E. J., Halpern, J., Torres, O. R., Hoffman, A. S., Villar, C. P., Kassem, R. N., Flyer, D. C., Andersen, B. H., Kazempour, K., Breisch, S. A., & Glenn, G. M.
Venue
The Lancet
Publisher
Elsevier BV
Published
2008-06
Volume
371
Issue
9629
Pages
2019-2025
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2105433670
Cited by
205
References
0
FWCI
22.32
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. https://app.cochat.ai/papers/10.1016/s0140-6736(08)60839-9
The paper
Frech, S. A., DuPont, H. L., Bourgeois, A. L., McKenzie, R., Belkind-Gerson, J., Figueroa, J. F., Okhuysen, P. C., Guerrero, N. H., Martinez-Sandoval, F. G., Meléndez-Romero, J. H., Jiang, Z.-D., Asturias, E. J., Halpern, J., Torres, O. R., Hoffman, A. S., Villar, C. P., Kassem, R. N., Flyer, D. C., Andersen, B. H., . . . Glenn, G. M. (2008). Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. The Lancet. https://doi.org/10.1016/s0140-6736(08)60839-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.